These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4800357)

  • 1. Brief communication: Specific colony inhibition by human lymphoma cells on an established human lymphoma cell line.
    Drewinko B; Mavligit G; Ambus U; Pritchett C; Gutterman J; Hersh E
    J Natl Cancer Inst; 1973 Oct; 51(4):1377-8. PubMed ID: 4800357
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of human lymphoma cell-line colony formation by lymphocytes from patients with lymphoma and cancer hospital employees.
    Drewinko B; Mavligit GM; Ambus U; Hersh EM
    Cancer; 1976 Jun; 37(6):2929-37. PubMed ID: 779948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of the adoptive transfer of specific tumor immunity by non-specifically immunized macrophages.
    Ariyan S; Gershon RK
    J Natl Cancer Inst; 1973 Oct; 51(4):1145-8. PubMed ID: 4583372
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell migration inhibition in human lymphomas using lymph node and cell line antigens.
    Braun M; Sen L; Bachmann AE; Pavlovsky A
    Blood; 1972 Mar; 39(3):368-76. PubMed ID: 4501089
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological aspects of non-Hodgkin's lymphomas.
    Bosco J
    Malays J Pathol; 1980 Aug; 3():5-8. PubMed ID: 7186597
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular immunity to human tumor-associated antigens. A review.
    Herberman RB
    Isr J Med Sci; 1973 Mar; 9(3):300-7. PubMed ID: 4575654
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunofluorescence studies of a lymphoid cell line derived from a patient with lymphocytic lymphoma.
    Trujillo JM; Shively JA; List-Young B; Gott CL
    Tex Rep Biol Med; 1969; 27(1):117-25. PubMed ID: 4889497
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic response in patients to cells of their own tumor.
    Albert Z; Harlozińska A; Richter R; Salwa J; Singer Z
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):455-63. PubMed ID: 4328728
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
    Stramignoni A; Navone R; Meriggi E
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
    Mukherji B; Nashed AL; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of a human immunoglobulin producing cell line grown "in vitro".
    Drewinko B; Trujillo JM; Barranco SC; Cork A; Brown BW
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):906-11. PubMed ID: 5172017
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of lymphoid cells in tumor-bearing mice.
    Gillette S; Bellanti JA
    Cell Immunol; 1973 Aug; 8(2):311-20. PubMed ID: 4740779
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigens of the Ii system on lymphocytes.
    Shumak KH; Rachkewich RA; Crookston MC; Crookston JH
    Nat New Biol; 1971 Jun; 231(22):148-9. PubMed ID: 4933258
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes.
    Nilsson K; Evrin PE; Welsh KI
    Transplant Rev; 1974; 21(0):53-84. PubMed ID: 4139789
    [No Abstract]   [Full Text] [Related]  

  • 15. NK and K cells in malignant lymph nodes.
    Milleck J; Jantscheff P; Irro F; Tkatscheva N; Lê Dinh Hóe
    Haematol Blood Transfus; 1983; 28():475-8. PubMed ID: 6574962
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural killer activity and NK cytotoxic factors in peripheral blood and lymph node cells from non-Hodgkin's lymphoma patients.
    Nadkarni JJ; Mehta BA; Koppikar SB; Soman CS; Shrikhande SS; Advani SH
    Neoplasma; 1989; 36(6):701-8. PubMed ID: 2615873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
    Mukherji B; Wilhelm SA; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HL-A and lymphoid tumors.
    Dick FR; Fortuny I; Theologides A; Greally J; Wood N; Yunis EJ
    Cancer Res; 1972 Dec; 32(12):2608-11. PubMed ID: 4509228
    [No Abstract]   [Full Text] [Related]  

  • 19. The nature of blood-borne cytotoxic cells. I. Cooperation between the white cells of the blood and lymph of sheep in the destruction of xenogeneic tumour cells in vitro.
    Grant CK; Glover DJ; Hall JG; Alexander P
    Transplantation; 1974 Mar; 17(3):254-64. PubMed ID: 4814197
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modern classifications of non-Hodgkin lymphomas].
    Iakovleva IA; Korchmaru IF
    Vopr Onkol; 1986; 32(6):3-17. PubMed ID: 3523992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.